Kleiner Perkins's Biotechnology Portfolio

ArsenalBio is a programmable cell therapy company that offers CAR T-cell therapies for solid tumors.

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

Optic is an AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validation.

Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.

Cell Design Labs is a biotherapeutics company

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.

ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

Zephyr Health operates as an insights-as-a-service solution built specifically for life sciences companies.

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.